RxSight, Inc. RXST
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Anthony Crowdell |
Mizuho Securities |
52 $ |
67 $ |
15.00 % |
29/10/2024 |
| Adam Seiden |
Barclays |
52 $ |
110 $ |
58.00 % |
29/10/2024 |
| Curry Baker |
Guggenheim |
52 $ |
52 $ |
0.00 % |
29/10/2024 |
| Young Li |
Jefferies |
50.25 $ |
72 $ |
21.75 % |
29/10/2024 |
| Ryan Zimmerman |
BTIG |
52.98 $ |
59 $ |
6.02 % |
23/09/2024 |
| David Saxon |
Needham |
54.54 $ |
66 $ |
11.46 % |
13/09/2024 |
| Thomas Stephan |
Stifel Nicolaus |
40.78 $ |
65 $ |
24.22 % |
06/08/2024 |
| David Saxon |
Needham |
47.145 $ |
54 $ |
6.86 % |
06/08/2024 |
| Steven Lichtman |
Oppenheimer |
62.84 $ |
72 $ |
9.16 % |
07/05/2024 |
| David Saxon |
Needham |
62.84 $ |
75 $ |
12.16 % |
07/05/2024 |
| Tom Stephan |
Stifel Nicolaus |
62.84 $ |
75 $ |
12.16 % |
07/05/2024 |
| Lawrence Biegelsen |
Wells Fargo |
62.84 $ |
68 $ |
5.16 % |
07/05/2024 |
| Ryan Zimmerman |
BTIG |
62.84 $ |
72 $ |
9.16 % |
07/05/2024 |
| Thomas Stephan |
Stifel Nicolaus |
61.68 $ |
68 $ |
6.32 % |
06/05/2024 |
| Lawrence Biegelsen |
Wells Fargo |
39.78 $ |
42 $ |
2.22 % |
13/12/2023 |
| David Saxon |
Needham |
30.86 $ |
34 $ |
3.14 % |
12/07/2023 |